Principia Biopharma Inc. PRNB
We take great care to ensure that the data presented and summarized in this overview for Principia Biopharma Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in PRNB
Top Purchases
Top Sells
About PRNB
Insider Transactions at PRNB
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 18
2019
|
Glaxosmithkline PLC |
BUY
Open market or private purchase
|
Indirect |
357,142
+10.69%
|
$9,999,976
$28.0 P/Share
|
|
May 21
2019
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,000,000
-38.38%
|
$30,000,000
$30.25 P/Share
|
|
Sep 18
2018
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
250,000
+8.75%
|
$4,250,000
$17.0 P/Share
|
|
Sep 18
2018
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,355,713
+21.73%
|
-
|
|
Sep 18
2018
|
Glaxosmithkline PLC |
BUY
Open market or private purchase
|
Indirect |
270,000
+9.32%
|
$4,590,000
$17.0 P/Share
|
|
Sep 18
2018
|
Glaxosmithkline PLC |
BUY
Conversion of derivative security
|
Indirect |
2,355,713
+21.73%
|
-
|
Last 12 Months Summary
Buy / Acquisition
0
Shares
From
0
Insiders
Sell / Disposition
0
Shares
From
0
Insiders